VolitionRx Secures Approximately $5.5 Million in Belgium Regional Government Financing from Wallonie Entreprendre PR Newswire HENDERSON, Nev., Dec. 5, 2023 HENDERSON, Nev. , Dec. 5, 2023 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has closed on an aggregate of Euro 5.0 million (approximately $5.5 million ) in financing from Wallonie Entreprendre S.A. ("WE") in Belgium . Volition will use the proceeds from the financing for ongoing...